Meningococcemia without meningitis in Japan

Internal Medicine

Volumn 47, Issue 17, 2008, Pages 1543-1547

  Horino, Tetsuya ^a   Kato, Tetsuro ^a   Sato, Fumiya ^a   Sakamoto, Mitsuo ^a   Nakazawa, Yasushi ^a   Yoshida, Masaki ^a   Onodera, Shoichi ^a   Kohda, Masato ^a   Matsuo, Koma ^a   Ishiji, Takaoki ^a   Takahashi, Hideyuki ^b   Watanabe, Haruo ^b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Fulminans purpura; Meningococcemia; Neisseria meningitidis

Indexed keywords

ANTIINFECTIVE AGENT; BETAMETHASONE; HYPERTENSIVE FACTOR; MEROPENEM; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G;

ADULT; ANTIMICROBIAL THERAPY; ARTHRALGIA; ARTICLE; BACTERIAL GROWTH; BLOOD CULTURE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEVER; FULMINATING PURPURA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; JAPAN; LABORATORY TEST; MENINGITIS; MENINGOCOCCEMIA; NEISSERIA MENINGITIDIS; NONHUMAN; PAIN; PATIENT REFERRAL; SEPTIC SHOCK; SKIN DEFECT; SKIN ULCER; VIRUS INFECTION;

ADULT; ANTI-INFECTIVE AGENTS; FEMALE; HUMANS; JAPAN; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS; PURPURA FULMINANS;

EID: 56349098123     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.1046     Document Type: Article

References (13)

1. Roenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JMN. Meningococcal disease. N Engl J Med 344: 1378-1388, 2001.
2. Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369: 2196-2210, 2007.
3. van Deuren M, Brandtzaeg P, van der Meer JW. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 13: 144-166, 2000.
4. Takahashi H, Kuroki T, Watanabe Y, et al. Characterization of Neisseria meningitidis isolates collected from 1974 to 2003 in Japan by multilocus sequence typing. J Med Microbiol 53: 657-662, 2004.
5. Aird WC. The hematologic system as a marker of organ dysfunction in sepsis. Mayo Clin Proc 78: 869-881, 2003.
6. Georges H, Leroy O, Vandenbussche C, et al. Epidemiological features and prognosis of severe community-required pneumococcal pneumonia. Intensive Care Med 25: 198-206, 1999.
7. Wolf RE, Birbara CA. Meningococcal infections at an army training center. Am J Med 44: 243-255, 1968.
8. Thompson MJ, Ninis N, Perera R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet 367: 397-403, 2006.
9. Nadel S, Kroll JS. Diagnosis and management of meningococcal disease: the need for centralized care. FEMS Microbiol Rev 31: 71-83, 2007.
10. Kuppermann N, Malley R, Inkelis SH, Fleisher GR. Clinical and hematologic features do not reliably identify children with unsuspected meningococcal disease. Pediatrics 103: E20, 1999.
11. Betrosian AP, Berlet T, Agarwal B. Purpura fulminans in sepsis. Am J Med Sci 332: 339-345, 2006.
12. van de, Beek D, Hensen EF, Spanjaard L, de Gans J, Enting RH, Dankert J. Meropenem susceptibility of Neisseria meningitidis and Streptococcus pneumoniae from meningitis patients in The Netherlands. J Antimicrob Chemother 40: 895-897, 1997.
13. Tanaka H, Kuroki T, Watanabe Y, et al. Isolation of Neisseria meningitidis from healthy persons in Japan. Kansenshogaku Zasshi 79: 527-533, 2005 (in Japanese, Abstract in English).